WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCWILLIAM BLAIR INVESTMENT MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2023

Top Holdings395 positions

Checking export access…
Activity:

Microsoft Corp.

3.5M$1.2B3.8%$212.73+56.09%
19 qtrssince 2018-Q4
Increased
61
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MFG LTD

11.4M$1.2B3.7%$47.78+101.91%
19 qtrssince 2018-Q4
Increased
60

Alphabet Inc.

5.7M$679.5M2.2%$88.41+34.11%
19 qtrssince 2018-Q4
Increased
60

Amazon.com, Inc.

4.8M$620.7M2.0%$115.39+12.97%
19 qtrssince 2018-Q4
Increased
53

Linde PLC

1.4M$537.2M1.7%$340.38+7.91%
2 qtrssince 2023-Q1
Increased
52

MasterCard Incorporated

1.2M$483.6M1.6%$272.53+41.56%
19 qtrssince 2018-Q4
Decreased
0

Canadian Pacific Kansas City Ltd.

5.7M$459.4M1.5%$78.010.00%
1 qtr
New
71

Mercadolibre Inc

387,611$459.2M1.5%$978.39+21.08%
17 qtrssince 2019-Q2
Increased
52

BWX TECHNOLOGIES INC

5.8M$414.3M1.3%$38.54+80.94%
19 qtrssince 2018-Q4
Decreased
0

BUILDERS FIRSTSOURCE INC

2.7M$367.7M1.2%$38.50+253.72%
12 qtrssince 2020-Q3
Decreased
0

UnitedHealth Group Inc.

763,781$367.1M1.2%$334.78+34.30%
19 qtrssince 2018-Q4
Increased
51

Encompass Health Corporation

5.3M$361.2M1.2%$45.70+44.69%
19 qtrssince 2018-Q4
Increased
49

CHEMED CORP NEW

560,171$303.4M1.0%$472.01+12.52%
8 qtrssince 2021-Q3
Decreased
0

EURONET WORLDWIDE INC

2.6M$299.7M1.0%$109.50+7.19%
19 qtrssince 2018-Q4
Decreased
0

CROWN HLDGS INC

3.3M$287.8M0.9%$66.09+26.54%
18 qtrssince 2019-Q1
Increased
50
GTLSGTLSDelisted

CHART INDS INC

1.8M$284.6M0.9%$158.18-0.51%
11 qtrssince 2020-Q4
Decreased
0

Merit Medical Systems Inc.

3.4M$282.3M0.9%$50.45+65.79%
15 qtrssince 2019-Q4
Decreased
0

INSPIRE MED SYS INC COM

836,162$271.5M0.9%$209.34+55.08%
11 qtrssince 2020-Q4
Decreased
0

CASELLA WASTE SYS INC CL A

3M$270.6M0.9%$76.16+18.76%
19 qtrssince 2018-Q4
Increased
44

Axon Enterprise Inc

1.4M$266.1M0.9%$95.68+104.67%
12 qtrssince 2020-Q3
Decreased
0
$31.2B
AUM
395
Positions
Q2 2023
Filing
HI score · 3.0/5
Quarterly 13F Value Change
-10%Q1'22$33.5B-19%Q2'22$27B-6%Q3'22$25.3B+3%Q4'22$26.1B+10%Q1'23$28.7B+9%Q2'23$31.2B
Activity profile
$ moved · Q2'23
New20%Increased42%Decreased25%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q6%1-4Q9%1-2Y16%2Y+69%

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC manages $31.2B across 395 positions as of Q2 2023. Top holdings: MSFT (3.8%), TSM (3.7%), GOOGL (2.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q2 2023 Summary

Active quarter - 34 new positions, 32 exits, 231 increased. Top move: CP (NEW, conviction 71). Portfolio: $31.2B across 395 positions.

Top holdings by portfolio weight

Total AUM$31B
MSFT3.81%
TSM3.70%
GOOGL2.18%
AMZN1.99%
LIN1.72%
MA1.55%
CP1.47%
MELI1.47%
BWXT1.33%
BLDR1.18%
Other1.18%

Portfolio allocation by GICS sector

Sectors11
Technology24.70%
Industrials15.85%
Healthcare15.16%
Consumer Cyclical14.66%
Financial Services8.03%
Consumer Defensive4.65%
Basic Materials4.29%
Communication Services3.45%
Unknown3.35%
Real Estate2.76%
Other3.11%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Industrials, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L60
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
DFINDFINDONNELLEY FINL SOLUTIONS INC
Q4 2024 → Q2 2026+309,869 shares+$5.3M
7Q
PWPPWPPERELLA WEINBERG PARTNERS
Q4 2024 → Q2 2026+3.2M shares+$46.8M
7Q
PRCTPRCTPROCEPT BIOROBOTICS CORP
Q4 2024 → Q2 2026+496,982 shares-$1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used